94 related articles for article (PubMed ID: 21427141)
1. Retinal vein thrombosis in a patient with metastatic colon cancer receiving XELOX chemotherapy combined with bevacizumab pre-hepatic resection.
Gilbar P; Sorour N
J Oncol Pharm Pract; 2012 Mar; 18(1):152-4. PubMed ID: 21427141
[TBL] [Abstract][Full Text] [Related]
2. XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study.
Rosati G; Avallone A; Aprile G; Butera A; Reggiardo G; Bilancia D
Cancer Chemother Pharmacol; 2013 Jan; 71(1):257-64. PubMed ID: 23100174
[TBL] [Abstract][Full Text] [Related]
3. [A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab].
Murayama M; Kohno T; Miyazawa M; Shimazaki A; Miyaki A; Usuda A; Asaka S; Yamaguchi K; Yokomizo H; Shiozawa S; Yoshimatsu K; Shimakawa T; Katsube T; Naritaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2014-6. PubMed ID: 24393997
[TBL] [Abstract][Full Text] [Related]
4. [A case of transverse colon cancer with multiple liver metastases and hepatic pedicle lymph node involvement showing pathological complete response by XELOX plus bevacizumab].
Mukai T; Akiyoshi T; Koga R; Arita J; Saiura A; Ikeda A; Nagasue Y; Oikawa Y; Yamakawa K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Suenaga M; Mizunuma N; Shinozaki E; Yamamoto C; Yamaguchi T
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2561-3. PubMed ID: 23235180
[TBL] [Abstract][Full Text] [Related]
5. [Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].
Sato A; Doi T; Boku N; Kato K; Komatsu Y; Yamaguchi K; Muro K; Hamamoto Y; Koizumi W; Mizunuma N; Takiuchi H
Gan To Kagaku Ryoho; 2011 Apr; 38(4):561-9. PubMed ID: 21498982
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.
Cassidy J; Clarke S; Díaz-Rubio E; Scheithauer W; Figer A; Wong R; Koski S; Lichinitser M; Yang TS; Rivera F; Couture F; Sirzén F; Saltz L
J Clin Oncol; 2008 Apr; 26(12):2006-12. PubMed ID: 18421053
[TBL] [Abstract][Full Text] [Related]
7. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.
Schmoll HJ; Cartwright T; Tabernero J; Nowacki MP; Figer A; Maroun J; Price T; Lim R; Van Cutsem E; Park YS; McKendrick J; Topham C; Soler-Gonzalez G; de Braud F; Hill M; Sirzén F; Haller DG
J Clin Oncol; 2007 Jan; 25(1):102-9. PubMed ID: 17194911
[TBL] [Abstract][Full Text] [Related]
8. Combining capecitabine and bevacizumab in metastatic breast cancer: a comprehensive review.
Miles D; Zielinski C; Martin M; Vrdoljak E; Robert N
Eur J Cancer; 2012 Mar; 48(4):482-91. PubMed ID: 22257791
[TBL] [Abstract][Full Text] [Related]
9. Sequential or combination chemotherapy for a patient with mCRC?
Arnold D
Cancer Treat Rev; 2008; 34 Suppl 2():S12-6. PubMed ID: 19101403
[TBL] [Abstract][Full Text] [Related]
10. [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].
Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):801-3. PubMed ID: 21223682
[No Abstract] [Full Text] [Related]
11. [Our experience of the treatment with XELOX±Bevacizumab for unresectable advanced colorectal cancer].
Kashiwagi S; Maeda K; Fuyuhiro Y; Nagahara H; Kimura K; Amano R; Noda E; Kubo N; Tanaka H; Muguruma K; Yashiro M; Yamada N; Nakata B; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1936-8. PubMed ID: 22202244
[TBL] [Abstract][Full Text] [Related]
12. Dural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI/bevacizumab.
Ozen A; Cicin I; Sezer A; Uzunoglu S; Saynak M; Genchellac H; Karagol H
J Cancer Res Ther; 2009; 5(2):130-2. PubMed ID: 19542672
[TBL] [Abstract][Full Text] [Related]
13. Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients.
Coskun U; Buyukberber S; Yaman E; Uner A; Er O; Ozkan M; Dikilitas M; Oguz M; Yildiz R; B DY; Kaya AO; Benekli M
Neoplasma; 2008; 55(1):65-70. PubMed ID: 18190244
[TBL] [Abstract][Full Text] [Related]
14. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.
Cassidy J; Tabernero J; Twelves C; Brunet R; Butts C; Conroy T; Debraud F; Figer A; Grossmann J; Sawada N; Schöffski P; Sobrero A; Van Cutsem E; Díaz-Rubio E
J Clin Oncol; 2004 Jun; 22(11):2084-91. PubMed ID: 15169795
[TBL] [Abstract][Full Text] [Related]
15. Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer.
Larsen FO; Boisen MK; Fromm AL; Jensen BV
Acta Oncol; 2012 Feb; 51(2):231-3. PubMed ID: 21936753
[TBL] [Abstract][Full Text] [Related]
16. Commentary on a phase III trial of bevacizumab plus XELOX or FOLFOX4 for first-line treatment of metastatic colorectal cancer: the NO16966 trial.
Tyagi P; Grothey A
Clin Colorectal Cancer; 2006 Nov; 6(4):261-4. PubMed ID: 17241510
[TBL] [Abstract][Full Text] [Related]
17. Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab.
Black JM; Hodari KT; Rogers N; Farris PK; Lewis AT; Boh EE
Arch Dermatol; 2011 Jan; 147(1):134-5. PubMed ID: 21242416
[No Abstract] [Full Text] [Related]
18. [A case of recurrent colon cancer developed thrombosis in superior mesenteric vein after chemotherapy].
Furuyama H; Fuji H; Okumura S; Nishigori T; Kadokawa Y; Kondo M; Machimoto T; Asao Y; Yoshimura T
Gan To Kagaku Ryoho; 2013 May; 40(5):659-61. PubMed ID: 23863595
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
Miller KD; Chap LI; Holmes FA; Cobleigh MA; Marcom PK; Fehrenbacher L; Dickler M; Overmoyer BA; Reimann JD; Sing AP; Langmuir V; Rugo HS
J Clin Oncol; 2005 Feb; 23(4):792-9. PubMed ID: 15681523
[TBL] [Abstract][Full Text] [Related]
20. [A case wherein bevacizumab/XELOX combination therapy was remarkably effective for the treatment of extensive dissemination in advanced colon cancer, and the primary lesion could be resected].
Kubo H; Nakasuga C; Tada K; Miyahara M; Hasegawa H
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1545-8. PubMed ID: 24231712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
